share_log

翰森製藥：自願公告 - 根據受限制股份單位計劃購買股份

HANSOH PHARMA: VOLUNTARY ANNOUNCEMENT - SHARE PURCHASE PURSUANT TO THE RESTRICTED SHARE UNIT SCHEME

香港交易所 ·  Jan 31 03:30
Summary by Moomoo AI
翰森製藥集團有限公司於2024年1月17日至1月23日期間，根據其受限制股份單位計劃，在市場上購入總計3,000,000股股份。該批股份的平均購入價格約為每股12.3015港元，總代價為36,904,560港元。此次股份購入後，受限制股份單位受託人持有的股份數目增至12,614,700股。公司董事會將繼續根據上市規則，檢討及決定未來根據該計劃授予的受限制股份單位數目及購買股份的數目。
翰森製藥集團有限公司於2024年1月17日至1月23日期間，根據其受限制股份單位計劃，在市場上購入總計3,000,000股股份。該批股份的平均購入價格約為每股12.3015港元，總代價為36,904,560港元。此次股份購入後，受限制股份單位受託人持有的股份數目增至12,614,700股。公司董事會將繼續根據上市規則，檢討及決定未來根據該計劃授予的受限制股份單位數目及購買股份的數目。
Hansen Pharmaceutical Group Limited purchased a total of 3,000,000 shares on the market from January 17 to January 23, 2024 under its Restricted Share Unit Plan. The average purchase price of this batch of shares is approximately HK$12.3015 per share for a total price of HK$36,904,560. Following this share repurchase, the number of shares held by the Trustees of the Restricted Share Units increased to 12,614,700 shares. The Board of Directors will continue to review and decide on the number of restricted share units to be granted under the plan in the future and the number of shares to be purchased in accordance with the Listing Rules.
Hansen Pharmaceutical Group Limited purchased a total of 3,000,000 shares on the market from January 17 to January 23, 2024 under its Restricted Share Unit Plan. The average purchase price of this batch of shares is approximately HK$12.3015 per share for a total price of HK$36,904,560. Following this share repurchase, the number of shares held by the Trustees of the Restricted Share Units increased to 12,614,700 shares. The Board of Directors will continue to review and decide on the number of restricted share units to be granted under the plan in the future and the number of shares to be purchased in accordance with the Listing Rules.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more